WhatA structured, task-oriented review platform where developers submit real-world LLM performance reports by use case, with CC-licensed data dumps for researchers and buyers.
SignalDevelopers are frustrated that model selection relies on vendor marketing and synthetic benchmarks that don't reflect real-world performance — multiple commenters describe wildly divergent experiences on coding, compiler work, frontend, and backend tasks, and one commenter has already started building this at model.reviews.
Why NowThe proliferation of frontier models (Opus variants, GPT-5.x, Fable) with overlapping claims but divergent real-world performance has made task-specific comparison an acute pain point for teams spending real money.
MarketSoftware teams and individual developers choosing between 10+ frontier models; adjacent to the developer tools market. No incumbent owns structured, community-sourced model reviews — existing options are Reddit threads and blog posts.
MoatNetwork effects from a growing corpus of structured, real-world reviews and CC-licensed data that becomes the canonical reference — similar to Stack Overflow's early moat.
CRISPR Delivery Platform for Solid Tumor TherapeuticsP7/10A biotech company focused specifically on solving the delivery problem for CRISPR-based cancer therapies, developing novel lipid nanoparticle or viral vector systems that can efficiently transport CRISPR payloads to solid tumors in vivo.
CRISPR Cancer Diagnostics for Undruggable MutationsP6/10A diagnostic platform that profiles patients' tumors for the specific genomic amplifications and mutations that CRISPR-shredding approaches can target, enabling oncologists to match patients to emerging CRISPR therapies.
Biotech Translation Tracker for Informed InvestorsC5/10A platform that tracks the real progress of preclinical and clinical-stage biotech breakthroughs — from lab results through delivery challenges, trial phases, and regulatory milestones — giving investors and patients an honest, hype-free assessment of how close therapies actually are to market.
Viral Vector Therapy Development Platform as ServiceC6/10A contract development platform that helps biotech startups and academic labs design, optimize, and manufacture viral vector (AAV/lentivirus) delivery systems for gene therapies, positioning as the picks-and-shovels play in gene therapy.
Automated Cost Guardrails for AI Agent OperationsP7/10A middleware layer that sits between AI agents and cloud/API services, enforcing hard spending limits, rate controls, and anomaly detection before any resource is consumed.
Prepaid Spending Caps for Cloud and API ServicesC6/10A financial wrapper service that lets developers provision hard-capped, prepaid budgets for cloud and API usage — once the balance hits zero, all calls stop instantly.